by Cartography | Oct 5, 2025
Mike has responsibility for growing venture investment transactions and managing equity investments aligned with future directions of Pfizer. He currently has responsibility for Pfizer’s investments in Anjarium Biosciences, Autobahn Therapeutics, Capstan Therapeutics,...
by Cartography | Sep 6, 2025
Troy Wilson is a serial entrepreneur whose passion lies in building exceptional biotech companies to advance patient care. As co-founder, President, Chief Executive Officer, and Chairman of the Board of Kura Oncology (NASDAQ: KURA) since its inception, Dr. Wilson and...
by Cartography | Feb 9, 2024
Kevin Parker is the CEO and co-founder of Cartography Biosciences. Kevin completed his PhD at Stanford working in the interface of genomics, immunology, and computational biology. He holds a B.A. in Human Developmental and Regenerative Biology from Harvard...
by Cartography | Nov 17, 2023
by Cartography | Nov 15, 2023
Becky Pferdehirt is an investing partner on the a16z Bio + Health team. Prior to joining Andreessen Horowitz, Becky worked at Amgen where she most recently led business development efforts for therapeutic platform partnerships. Before moving to BD Becky was a research...
